Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|June 12, 2024
No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavirTracy L Diamond, Shih Lin Goh, Winnie Ngo, et al.Antimicrobial Agents and Chemotherapy|May 12, 2022
Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs)Tracy L Diamond, Winnie Ngo, Min Xu, et al.Antimicrobial Agents and Chemotherapy|May 2, 2022
Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to ResistanceMing-Tain Lai, Meizhen Feng, Min Xu, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2020
Review of Doravirine Resistance Patterns Identified in Participants During Clinical DevelopmentElizabeth Anne Martin, Ming-Tain Lai, Winnie Ngo, et al.Protein Expression and Purification|January 12, 2010
Purification of untagged HIV-1 reverse transcriptase by affinity chromatographyMeiqing Lu, Winnie Ngo, Ye Mei, et al.The Journal of Infectious Diseases|December 16, 2025
Weekly Oral Prophylaxis With MK-8527 Protects Rhesus Macaques From Intrarectal Challenge With Simian-Human Immunodeficiency VirusTracy L Diamond, Yash Kapoor, Fangbiao Li, et al.Pageof 1